Investical Earnings & investing calendar Earnings & investing calendar
/
DDAIKEN MEDICAL CO.,LTD. logo
7775TSE Standard

DAIKEN MEDICAL CO.,LTD.

大研医器 Yahoo Finance

Recent & upcoming events

Oct 30
Earnings 2:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
Sep 28
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Sep 27
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Jul 31
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 23
Shareholder meeting 21:00
Shareholders' meeting
Venue: リーガロイヤルホテル大阪 ヴィニェットコレクション 2階 山楽の間 大阪市北区中之島5丁目3番68号 Details
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Oct 30
Earnings 2:00 approx.
Q2 earnings announcement (scheduled)
Add to Google Calendar
2027
Jan 15
Est.
Earnings 1:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
Apr 2
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Jun 18
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Sep 3
Est.
Earnings 2:00 approx.
Earnings announcement (predicted)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar

KPI highlights

FY26
Revenue ¥10.29B YoY +3.4%
Operating income ¥1.28B margin 12.4%
Net income ¥923M YoY -15.9%
EPS —
P/E —
ROE —

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥10.50B +2.0%
Operating income ¥840M -34.3%
Net income ¥590M -36.1%
EPS ¥21 —

Quarterly fundamentals

Income & cash flow
Quarter FY23 Q1FY23 Q2FY23 Q3FY23 Q4FY24 Q1FY25 Q2
Revenue ¥2.24B¥2.36B—¥2.58B¥2.34B—
Operating income ¥85M¥339M—¥492M¥205M—
Net income ¥24M¥245M—¥350M¥100M—
Operating CF ——————

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2021–2026）

個人 51%その他 3.5%未開示 45.5%202120222023202420252026
国内機関個人その他未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

山田　圭一 19%山田　圭一山田　満 13.9%山田　満山田　雅之 10.9%山田　雅之公益財団法人山田満育英会 3.5%公益財団法人山田満育英会関家　圭三 3.3%関家　圭三202120222023202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
山田 圭一 5,462,000 19.0% Yuho (EDINET)
山田 満 4,000,000 13.9% Yuho (EDINET)
山田 雅之 3,129,000 10.9% Yuho (EDINET)
公益財団法人山田満育英会 1,000,000 3.5% Yuho (EDINET)
関家 圭三 950,000 3.3% Yuho (EDINET)
大研医器従業員持株会 266,000 0.9% Yuho (EDINET)
寺田 恭子 258,000 0.9% Yuho (EDINET)
羽根 一徳 200,000 0.7% Yuho (EDINET)
山田 すみれ 200,000 0.7% Yuho (EDINET)
磐下 裕司 179,000 0.6% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

4/9 4 of 9 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 8.1%
— Positive operating cash flow No data
✗ ROA improved YoY 9.8% → 8.1%
— Operating CF exceeds net income (accrual quality) No data
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 67.2% → 68.4%
— Current ratio improved No data
✓ No dilution (shares outstanding did not increase) 31,840,000 → 31,840,000
— Gross margin improved No data
✓ Asset turnover improved 0.89× → 0.91×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio —
Current ratio —
Years of positive operating CF 6 of last 6 yrs
Payout ratio 62%
Latest fiscal year result Profit (net income ¥923M)

Performance history

Last 10 years
0億円26億円51億円77億円103億円 FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
Revenue 84.085.984.185.278.685.491.497.599.5103
Operating income 17.115.112.511.99.2111.510.514.415.112.8
Ordinary income 17.115.012.512.19.5711.510.514.515.112.7
Net income 12.510.18.528.606.758.317.129.8911.09.23
Total assets 110111110110108109110110112114
Equity 72.866.957.760.861.864.566.070.275.277.8

Indicators & cash flow

Unit: ¥100M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26
EPS ———¥30¥24¥29¥25¥34¥38—
ROE ——————————
Operating CF ———13.57.7012.99.6416.614.7—
Investing CF ———-1.09-3.08-1.96-2.09-1.62-1.67—
Financing CF ———-11.2-4.83-5.78-7.70-11.5-6.88—
FCF ———12.72.979.307.9013.99.53—

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Key financial metrics

3-year revenue growth ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data